ES2000359A6 - Procedimiento para la obtencion de 3-aminosidnoniminas substituidas - Google Patents

Procedimiento para la obtencion de 3-aminosidnoniminas substituidas

Info

Publication number
ES2000359A6
ES2000359A6 ES8600397A ES8600397A ES2000359A6 ES 2000359 A6 ES2000359 A6 ES 2000359A6 ES 8600397 A ES8600397 A ES 8600397A ES 8600397 A ES8600397 A ES 8600397A ES 2000359 A6 ES2000359 A6 ES 2000359A6
Authority
ES
Spain
Prior art keywords
denotes
substituted
amino
compounds
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600397A
Other languages
English (en)
Inventor
Karl Schonafinger
Rudi Beyerle
Helmut Bohn
Melitta Just
Rolf Eberhard Nitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Cassella AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG filed Critical Cassella AG
Publication of ES2000359A6 publication Critical patent/ES2000359A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 3-AMINOSIDNONIMINAS SUBSTUITUIDAS, OPTICAMENTE ACTIVAS, DE LA FORMULA GENERAL (I) Y SUS SALES DE ADICION DE ACIDO FARMACOLOGICAMENTE ACEPTABLES EN LA QUE LOS SUSTITUYENTES TIENEN LOS SIGNIFICADOS INDICADOS EN LA DESCRIPCION, POR REACCION DE COMPUESTOS DE LA FORMULA (III) CON COMPUESTOS DE FORMULA (IV).
ES8600397A 1985-07-20 1986-07-18 Procedimiento para la obtencion de 3-aminosidnoniminas substituidas Expired ES2000359A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853526068 DE3526068A1 (de) 1985-07-20 1985-07-20 Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
ES2000359A6 true ES2000359A6 (es) 1988-02-16

Family

ID=6276354

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600397A Expired ES2000359A6 (es) 1985-07-20 1986-07-18 Procedimiento para la obtencion de 3-aminosidnoniminas substituidas

Country Status (16)

Country Link
US (1) US4845091A (es)
EP (1) EP0210474B1 (es)
JP (1) JPS6222775A (es)
KR (1) KR870001203A (es)
AT (1) ATE56000T1 (es)
AU (1) AU6030886A (es)
DE (2) DE3526068A1 (es)
DK (1) DK343186A (es)
ES (1) ES2000359A6 (es)
FI (1) FI862963A7 (es)
GR (1) GR861863B (es)
HU (1) HU195199B (es)
PH (1) PH23027A (es)
PL (1) PL260714A1 (es)
PT (1) PT83012B (es)
ZA (1) ZA865370B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702083A1 (de) * 1987-01-24 1988-08-04 Cassella Ag Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3819914A1 (de) * 1988-06-11 1989-12-21 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3820210A1 (de) * 1988-06-14 1989-12-21 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
JPH02220844A (ja) * 1989-02-22 1990-09-04 Bridgestone Corp 多層複合成形体及びその製造方法
DE3921460A1 (de) * 1989-06-30 1991-01-03 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921796A1 (de) * 1989-07-03 1991-01-17 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4031373A1 (de) * 1990-10-04 1992-04-09 Cassella Ag 3-piperazino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4216310A1 (de) * 1992-05-16 1993-11-18 Cassella Ag Salze von 3-(cis-2,6-Dimethylpiperidino)-sydnonimin
DE19961523C2 (de) * 1999-12-20 2003-05-08 Siemens Ag Verfahren zum Betrieb eines mit unterschiedlichen Bildformaten auf dem Eingangsbildschirm betreibbaren Röntgenbildverstärkers
GB0025213D0 (en) * 2000-10-14 2000-11-29 Avecia Bv Polyester polymer compositions
US6867194B2 (en) 2001-08-09 2005-03-15 Wayne State University Enzyme activated nitric oxide donors
CN104761564B (zh) * 2008-03-24 2017-06-06 阿彻丹尼尔斯米德兰德公司 脱水糖醚的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695897C3 (de) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US3833580A (en) * 1966-08-09 1974-09-03 Boehringer Sohn Ingelheim 3-morpholino-n6-cyclohexylcarbonyl sydnonimine
DE2930736A1 (de) * 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
US4277609A (en) * 1979-08-31 1981-07-07 American Home Products Corporation Sydnone imines
DE3107933A1 (de) * 1981-03-02 1982-09-16 Cassella Ag, 6000 Frankfurt Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
JPS5859977A (ja) * 1981-10-06 1983-04-09 Banyu Pharmaceut Co Ltd 新規なｎ−アシルシドノンイミン誘導体およびその製法

Also Published As

Publication number Publication date
ATE56000T1 (de) 1990-09-15
DE3673720D1 (de) 1990-10-04
US4845091A (en) 1989-07-04
DE3526068A1 (de) 1987-01-22
FI862963A0 (fi) 1986-07-16
AU6030886A (en) 1987-01-22
EP0210474B1 (de) 1990-08-29
GR861863B (en) 1986-11-17
PL260714A1 (en) 1987-04-06
HUT41751A (en) 1987-05-28
PT83012B (de) 1987-12-04
ZA865370B (en) 1987-02-25
JPS6222775A (ja) 1987-01-30
EP0210474A1 (de) 1987-02-04
PT83012A (de) 1986-08-01
PH23027A (en) 1989-03-10
DK343186A (da) 1987-01-21
HU195199B (en) 1988-04-28
DK343186D0 (da) 1986-07-18
KR870001203A (ko) 1987-03-12
FI862963A7 (fi) 1987-01-21

Similar Documents

Publication Publication Date Title
ES2000359A6 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas
AU2736088A (en) Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
IE872658L (en) Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
IL68093A0 (en) Theophyllinyl-alkyl-oxadiazoles,process for the preparation thereof and pharmaceutical compositions containing them
AU586086B2 (en) 1,5-benzothiazepine derivatives, their preparation and compositions containing them
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
ATE43350T1 (de) Nor-cholsaeure-derivate, verfahren zu ihrer herstellung, ihre anwendung und pharmazeutische zusammenstellungen, die sie enthalten.
ATE13882T1 (de) 1-((substituierte-naphthyl)aethyl)imidazolderivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
IL74921A (en) 4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them
ES8501382A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico.
IL66384A (en) Indolin-2-one(3,4-dihydroquinol-2-one or quinol-2-one)-oxyalkylsulphimines and salts thereof,their preparation and pharmaceutical compositions containing them
ES8706623A1 (es) Procedimiento de preparar compuestos amidicos farmacologicamente activos
ES8307233A1 (es) Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico.
ATE23155T1 (de) Aminozyklopentanol saeure und ester, ein verfahren zu ihrer herstellung und ihre pharmazeutische zusammensetzung.
ATE29251T1 (de) Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU567498B2 (en) 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives.
ES8201575A1 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles
HUT43058A (en) Process for preparing substituted pyrrolidinone derivatives and pharmaceutical compositions containing thereof
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
IL70103A0 (en) Semicarbazides,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-07-18

FD1A Patent lapsed

Effective date: 20001102